Forecasted revenue of mRNA market revenue worldwide 2021-2035

Published by
Matej Mikulic,
Sep 16, 2021
In 2021, revenues of mRNA products will come only from COVID-19 vaccines, forecasted to reach around 21 billion U.S. dollars worldwide. This statistic illustrates the forecasted revenue of mRNA products worldwide from 2021 to 2035.

Forecasted mRNA product revenue worldwide from 2021 to 2035* (in billion U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

September 2021

Region

Worldwide

Survey time period

as of September 2021

Supplementary notes

* Risk-adjusted revenues. The source did not provide forecasts for some years.
** 2021 figures represent only approximate COVID-19 vaccine sales.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " mRNA technology "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you mRNA technology

Overview

5

Research and development

5

COVID-19

6

Leading companies

4

Focus: Moderna

5

Focus: BioNTech

4

Further related statistics

15

Further Content: You might find this interesting as well

Statistics

Topics

Global pharmaceutical industryPfizerBioNTechVaccinations in the U.S.Coronavirus disease (COVID-19) pandemic
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu